COVID-19 Vaccine For 5- To 11-Year-Olds Is Safe And Shows 'Robust' Antibody Response, Pfizer Says
PHILADELPHIA (CNN) --- In a highly anticipated announcement, Pfizer said on Monday a Phase 2/3 trial showed its COVID-19 vaccine was safe and generated a "robust" antibody response…
